Author:
Achemlal Lahsen,Mikdame Mohamed,Nouijai Abderrazak,Bezza Ahmed,El Maghraoui Abdellah
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference8 articles.
1. Ostrowski ML, Unni KK, Banks PM, Shives TC, Evans RG, O'Connell MJ et al (1986) Malignant lymphoma of bone. Cancer 58:2646–2655
2. Parker F, Jackson H (1939) Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet 68:45–53
3. Fidias P, Spiro I, Sobczak ML, Nielsen GP, Ruffolo EF, Mankin H et al (1999) Long-term results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys 45:1213–1218
4. Coiffier B, Haioun C, Ketterer N, Engert A, Tilly H, Ma D et al (1998) Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 92:1927–1932
5. Maloney DG, Grillo-Lopez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA et al (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188–2195
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献